Efficacy and Safety of Guduchi Ghan Vati for Covid-19 Asymptomatic Patients
NCT ID: NCT04480398
Last Updated: 2020-07-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
91 participants
OBSERVATIONAL
2020-05-12
2020-07-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
With recommended guidelines of AYUSH Ministry, India, the use of Ayurveda for Covid-19 has increased; however, its efficacy and safety in Covid-19 confirmed patients remain unclear.
Present study examined the efficacy and safety of one of the recommended Ayurveda drug (Guduchi Ghan Vati) compared with standard care for patients with asymptomatic Covid-19 patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection
NCT04542876
Community-based Post-exposure Prophylaxis for COVID-19
NCT04920773
A Pilot Study on Efficacy and Safety of Ayurveda Combination in Patients With Mild-to-Moderate COVID-19
NCT04621903
Ayurveda as Prophylaxis for Suspected COVID-19 Patients
NCT04395976
Ayurveda for Flu Like Illness During Covid-19 Outbreak
NCT04351542
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ayurveda
Guduchi Ghan Vati was given to Covid patients 2 tablets (500 mg each) twice daily were given orally after meal for 28 days. Guduchi ghan vati is a powdered aqueous extract of Tinospora cordifolia in tablet form and prepared in GMP certified Pharmacy of the University, following standard protocol.
Guduchi Ghan Vati
Guduchi Ghan Vati is an Ayuvedic classical preparation which is prepared from aqueous of extract of Tinospora cordifolia.
Control
Standard care for asymptomatic confirmed cases is isolation (to contain virus transmission) and clinical monitoring as per recommended Guidelines.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Guduchi Ghan Vati
Guduchi Ghan Vati is an Ayuvedic classical preparation which is prepared from aqueous of extract of Tinospora cordifolia.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A person diagnosed with COVID-19
* Asymptomatic at the time of admission
Exclusion Criteria
* Taking antibiotics or antiretroviral for any reason
* Mild to Moderate symptoms at the time of hospital admission
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University
OTHER
Samta Ayurveda Prakoshtha, India
UNKNOWN
Aarogyam UK
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Parashar Sharma
Role: STUDY_CHAIR
Samta Ayurveda Prakoshtha
Jaydeep Joshi
Role: STUDY_CHAIR
Aarogyam UK
Neha Sharma
Role: STUDY_DIRECTOR
Aarogyam UK
Abhimanyu Kumar
Role: PRINCIPAL_INVESTIGATOR
Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University
Jodhpur, Rajasthan, India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AYU/DSSR/02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.